TY - JOUR AU - Dunlop, Joanna Leigh AU - Vandal, Alain Charles AU - de Zoysa, Janak Rashme AU - Gabriel, Ruvin Sampath AU - Haloob, Imad Adbi AU - Hood, Christopher John AU - Matheson, Philip James AU - McGregor, David Owen Ross AU - Rabindranath, Kannaiyan Samuel AU - Semple, David John AU - Marshall, Mark Roger PY - 2015 DA - 2015/08/01 TI - Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass JO - BMC Nephrology SP - 120 VL - 16 IS - 1 AB - After the publication of our paper Dunlop et al. “Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass”, we became aware of further data correlating left ventricular (LV) mass index at baseline and their correpsonding mass at 12 months, using cardiac margnetic resonanace imaging (MRI) in patients on hemodialysis. The original published sample size for the SoLID trial of 118 was a conservative estimate, calculated using analysis of covariance and a within person Pearson’s correlation for LV mass index of 0.75. New data communicated to the SoLID trial group has resulted in re-calcuation of the sample size, based upon a within person Pearson’s correlation of 0.8 but otherwise unchanged assumptions. As a result, the SoLID trial will now recruit 96 participants. SN - 1471-2369 UR - https://doi.org/10.1186/s12882-015-0080-y DO - 10.1186/s12882-015-0080-y ID - Dunlop2015 ER -